MetaVia

Boston, United States

MetaVia is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies.

$9.3M raised

Jan 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MetaVia raised?

MetaVia has raised $9.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.

Who are MetaVia's investors?

MetaVia's investors include Silicon Valley Bank.

Where is MetaVia headquartered?

MetaVia is headquartered in Boston, United States.

What does MetaVia do?

MetaVia is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies.

What stage is MetaVia at?

MetaVia is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 15, 2026.

MLA

"MetaVia — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/metavia. Accessed July 4, 2026.

APA

VCBacked. (2026). MetaVia — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/metavia

Wikipedia (cite web)

{{cite web |title=MetaVia — Funding & Investors |url=https://www.vcbacked.co/company/metavia |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 15, 2026.